Offsets |
Jul. 31, 2026
USD ($)
|
|---|---|
| Offset: 1 | |
| Offset Payment: | |
| Offset Claimed | true |
| Rule 457(b) Offset | true |
| Form or Filing Type | S-1 |
| File Number | 333-299332 |
| Initial Filing Date | Oct. 06, 2026 |
| Fee Offset Claimed | $ 2,375.73 |
| Explanation for Claimed Amount | The Company previously paid $2,375.73 with respect to common stock included herein based on a maximum aggregate offering price of $34,500,000.00 in connection with its filing of the Registration Statement on Form S-1 (File No. 333-299332) on October 6, 2026. In accordance with Rule 457(b) under the Securities Act, the Company is using $2,375.73 of the previously paid fees to offset the filing fee payable in connection with this Registration Statement. |
| Offset: 2 | |
| Offset Payment: | |
| Offset Claimed | false |
| Rule 457(b) Offset | true |
| Registrant or Filer Name | Actuate Therapeutics, Inc. |
| Form or Filing Type | S-1 |
| File Number | 333-299332 |
| Filing Date | Oct. 06, 2026 |
| Fee Paid with Fee Offset Source | $ 2,375.73 |